Supreme Petrochem Ltd

- Supreme Petrochem Limited remains debt-free as of March 2026. - The company has an investable surplus of INR 700 crores. - All capital expenditures are funded through internal accruals. - There is no mention of any current or planned fundraising through debt or equity. - The company is cautious with CAPEX, especially in Haryana, linked to upstream project timelines. - Overall, no new external fundraising through debt or equity is indicated in the report.

- EPS Phase-II expansion at Nagothane commissioned in April 2026, increasing capacity from 85,000 to 115,000 tons per annum. - ABS mass plant restarted with modified arrangements, currently operating at ~65% capacity; aiming to reach 80-90% utilization in FY27. - Phase-II ABS expansion planned for FY28; work progressing irrespective of current equipment issues. - Haryana CAPEX for FY27 is limited to infrastructure and related activities due to delayed IOC styrene monomer plant; major spending on PS and EPS pending clearer commissioning timeline. - Company-wide CAPEX guidance for FY27 is approximately INR 250 crores, funded entirely through internal accruals. - Future de-bottlenecking of polystyrene capacity under evaluation; timeline not yet finalized. Overall, Supreme Petrochem is focusing on capacity expansion in EPS and ABS, cautious Haryana investments, and internal funding for capex.

- The company expects an 8% to 10% volume growth in FY27, contingent on global market normalization by June-July 2026. - With ABS operational, overall volume growth aligns with market growth; however, Q1 FY27 might see lower growth due to ongoing global uncertainties. - The ABS plant currently operates at around 65-70% capacity with expectations to reach 80-90% utilization in FY27. - Phase two expansion of ABS is underway, independent of equipment issues, indicating future capacity increase. - The EPS Phase-II expansion was successfully commissioned in April 2026, increasing capacity from 85,000 to 115,000 tons per annum. - The company plans to continue volume growth in compounding divisions and production, aiming to reach 50,000 tons in SPC and Xmold divisions by FY28. - Operating EBITDA is expected to improve if the market situation normalizes post Q1 FY27.

- The company anticipates volume growth of 8-10% for the year if global conditions, including war impacts, normalize by June-July 2026. - EBITDA for FY27 is expected to be maintained at least at FY26 levels or potentially improve if market conditions normalize. - Operating cash flow may stabilize with a sustainable receivable cycle of 30-35 days following normalization of prices and material supply. - Expansion projects like EPS Phase-II and ABS Phase-II are progressing, expected to contribute to volume and earnings growth by FY27-FY28. - The company is focused on growing volumes alongside market growth and expects improved spreads and volumes once supply chain issues ease. - No specific EPS guidance was given, but improved volumes, better margins, and operational efficiencies hint at potential earnings growth.

- The transcript does not provide specific numerical details on the current or expected order book or pending orders for Supreme Petrochem Limited. - Discussions indicate ongoing demand and operations, with certain capacity utilizations (e.g., ABS plant at 65% of design capacity) and production volumes mentioned, but order backlog specifics are not disclosed. - Growth expectations are based on volume increases aligned with market growth (8-10% volume growth guidance mentioned). - Demand scenarios vary between OEM and non-OEM segments, with roughly a 50-50 split anticipated for some products. - External factors such as geopolitical situations and raw material supply constraints influence operational performance and market supply. - No explicit mention of order book size or pending orders in the available text.